According to
GuruFocus Insider Data
, these are the largest CEO buys during the past week. The
overall trend of CEOs is illustrated in the chart below:
Solar Senior Capital Ltd (
SUNS
): CEO, President Chn of the Brd Michael S Gross Bought 42,824
Shares
CEO, President Chn of the Brd of Solar Senior Capital Ltd (
SUNS
) Michael S Gross bought 42,824 shares during the past week at an
average price of $17.4. Solar Senior Capital Ltd. operates as a
business development company under the Investment Company Act of
1940. Solar Senior Capital Ltd has a market cap of $165.5
million; its shares were traded at around $17.4 with a P/E ratio
of 20.7 and P/S ratio of 21. The dividend yield of Solar Senior
Capital Ltd stocks is 7.2%.
SUNS recently reported earnings of $3.6 million, or $0.38 per
share, and net investment income of $3.4 million, or $0.36 per
share, for the quarter ended June 30, 2012. Net asset value (
NAV
) per share increased to $18.54, from $18.15 at December 31,
2011.
CFO, Secretary and Treasurer
Richard Peteka
bought 1,487 shares of SUNS stock on 05/31/2012 at the average
price of 16.45. Richard Peteka owns at least 6,250 shares after
this. The price of the stock has increased by 5.78% since. Other
insiders have also decreased their positions in the company.
Pacific Biosciences of California (
PACB
): Chairman, CEO & President Michael Hunkapiller Bought
400,000 Shares
Chairman, CEO & President of Pacific Biosciences of
California (
PACB
) Michael Hunkapiller bought 400,000 shares on 08/07/2012 at an
average price of $1.81. Pacific Biosciences of California, Inc.
is engaged in the development, manufacture and commercialization
of its single molecule, real-time, or SMRT technology-an
integrated platform for genetic analysis. Pacific Biosciences Of
California has a market cap of $94.4 million; its shares were
traded at around $1.81 with and P/S ratio of 2.8.
PACB recently reported its second quarter 2012 financial results.
Gross profit for the second quarter of 2012 totaled $0.3 million,
resulting in a gross margin of 4%, compared to a $0.2 million
gross loss for the first quarter of 2012 and a negative margin of
2%. Gross profit for the second quarter of 2011 was $7.9 million
representing a gross margin of 74%.
Jean-Marie Eveillard
bought 150,000 shares in the quarter that ended on 03/31/2012,
which is 0.002% of the $25.09 billion portfolio of First Eagle
Investment Management, LLC.
Lee Ainslie
owns 3,543,333 shares as of 03/31/2012, which accounts for 0.17%
of the $6.95 billion portfolio of Maverick Capital. John Griffin
owns 870,000 shares as of 03/31/2012, which accounts for 0.049%
of the $6.04 billion portfolio of Blue Ridge Capital.
General Motors Company (
GM
): Chairman & CEO Daniel F Akerson Bought 25,000
Shares
Chairman & CEO of General Motors Company (
GM
) Daniel F Akerson bought 25,000 shares on 08/08/2012 at an
average price of $20.54. General Motors Company is engaged in the
designing, manufacturing and retailing of vehicles globally
including passenger cars, crossover vehicles, and light trucks,
sport utility vehicles, vans and other vehicles. General Motors
Company has a market cap of $31.39 billion; its shares were
traded at around $20.54 with a P/E ratio of 6.2 and P/S ratio of
0.2.
GM recently announced second quarter net income attributable to
common stockholders of $1.5 billion, or $0.90 per fully diluted
share. In the second quarter a year ago, GM's net income
attributable to common stockholders was $2.5 billion, or $1.54
per fully diluted share.
Mohnish Pabrai bought 2,237,000 shares in the quarter that ended
on 06/30/2012, which is 18.3% of the $241 million portfolio of
Pabrai Mohnish. Richard Pzena bought 13,475 shares in the quarter
that ended on 06/30/2012, which is 0.0031% of the $8.56 billion
portfolio of Pzena Investment Management LLC. Ken Heebner sold
out his holdings in the quarter that ended on 03/31/2012.
Director Thomas M Schoewe bought 3,800 shares of GM stock on
03/05/2012 at the average price of 26.05. Thomas M Schoewe owns
at least 3,800 shares after this. The price of the stock has
decreased by 21.15% since. Other insiders have also decreased
their positions in the company.
EnPro Industries, Inc. (
NPO
): President and CEO Stephen E. Macadam Bought 13,900
Shares
President and CEO of EnPro Industries, Inc. (
NPO
) Stephen E. Macadam bought 13,900 shares on 08/07/2012 at an
average price of $34.04. EnPro Industries, Inc. is a leader in
sealing products, metal polymer bearings, compressor systems and
other engineered products for use in critical applications by
industries worldwide. Enpro Industries, Inc. has a market cap of
$668.6 million; its shares were traded at around $34.04 with a
P/E ratio of 11.6 and P/S ratio of 0.6.
EnPro Industries recently reported its second quarter 2012
financial results. Net income in the second quarter of 2012 was
$10.2 million, or $0.47 a share, compared to $12.2 million, or
$0.56 a share, in the second quarter of 2011.
John Keeley owns 1,142,881 shares as of 03/31/2012, which
accounts for 0.95% of the $4.94 billion portfolio of Keeley Fund
Management.
VP, GC and Secretary Robert Savage Mclean bought 1,130 shares of
NPO stock on 08/08/2012 at the average price of 32.65. Robert
Savage Mclean owns at least 7,830 shares after this. The price of
the stock has increased by 4.26% since. Other insiders have also
increased their positions in the company.
Quest Diagnostics Inc (
DGX
): President and CEO Stephen H Rusckowski Bought 5,000
Shares
President and CEO of Quest Diagnostics Inc (
DGX
) Stephen H Rusckowski bought 5,000 shares on 08/07/2012 at an
average price of $59.47. Quest Diagnostics Inc., is the provider
of diagnostic testing, information and services that patients and
doctors need to make better healthcare decisions. Quest
Diagnostics Inc has a market cap of $9.4 billion; its shares were
traded at around $59.47 with a P/E ratio of 12.7 and P/S ratio of
1.3. The dividend yield of Quest Diagnostics Inc stocks is 1.2%.
Quest Diagnostics Inc had an annual average earnings growth of
11.4% over the past 10 years. GuruFocus rated Quest Diagnostics
Inc the business predictability rank of 3.5-star.
Quest Diagnostics recently announced that for the second quarter
ended June 30, 2012, adjusted income from continuing operations
was $187 million, or $1.17 per diluted share, compared to $179
million, or $1.12 per diluted share, in 2011.
Richard Pzena bought 4,959 shares in the quarter that ended on
06/30/2012, which is 0.0035% of the $8.56 billion portfolio of
Pzena Investment Management LLC. Ray Dalio bought 34,998 shares
in the quarter that ended on 03/31/2012, which is 0.033% of the
$6.73 billion portfolio of Bridgewater Associates. Ray Dalio sold
out his holdings in the quarter that ended on 06/30/2012.
SVP & CFO Robert Hagemann sold 46,666 shares of DGX stock on
04/02/2012 at the average price of 62. Robert Hagemann owns at
least 156,337 shares after this. The price of the stock has
decreased by 4.08% since. Other insiders have also decreased
their positions in the company.About GuruFocus: GuruFocus.com
tracks the stocks picks and portfolio holdings of the world's
best investors. This value investing site offers stock screeners
and valuation tools. And publishes daily articles tracking the
latest moves of the world's best investors. GuruFocus also
provides promising stock ideas in 3 monthly newsletters sent to
Premium Members
.